These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20107430)

  • 1. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.
    Tiwari AK; Zai CC; Likhodi O; Lisker A; Singh D; Souza RP; Batra P; Zaidi SH; Chen S; Liu F; Puls I; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ
    Neuropsychopharmacology; 2010 May; 35(6):1315-24. PubMed ID: 20107430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.
    Tiwari AK; Brandl EJ; Weber C; Likhodi O; Zai CC; Hahn MK; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    J Clin Psychopharmacol; 2013 Feb; 33(1):11-7. PubMed ID: 23277265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
    Monteleone P; Milano W; Petrella C; Canestrelli B; Maj M
    J Clin Psychopharmacol; 2010 Aug; 30(4):441-5. PubMed ID: 20631561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.
    Souza RP; Tiwari AK; Chowdhury NI; Ceddia RB; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    J Psychiatr Res; 2012 Apr; 46(4):462-8. PubMed ID: 22305490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.
    Park YM; Choi JE; Kang SG; Koo SH; Kim L; Geum D; Lee HJ
    Hum Psychopharmacol; 2011; 26(4-5):332-7. PubMed ID: 21695734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.
    Tiwari AK; Zai CC; Likhodi O; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Müller DJ; Kennedy JL
    Pharmacogenomics J; 2012 Jun; 12(3):260-6. PubMed ID: 21266946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.
    Tiwari AK; Zai CC; Meltzer HY; Lieberman JA; Müller DJ; Kennedy JL
    Hum Psychopharmacol; 2010 Apr; 25(3):253-9. PubMed ID: 20373477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.
    Tiwari AK; Rodgers JB; Sicard M; Zai CC; Likhodi O; Freeman N; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1484-90. PubMed ID: 20732371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain.
    Czerwensky F; Leucht S; Steimer W
    J Clin Psychopharmacol; 2013 Feb; 33(1):74-9. PubMed ID: 23277235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.
    Gagliano SA; Tiwari AK; Freeman N; Lieberman JA; Meltzer HY; Kennedy JL; Knight J; Müller DJ
    Hum Psychopharmacol; 2014 Jul; 29(4):330-5. PubMed ID: 24737441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans.
    Maciukiewicz M; Tiwari AK; Zai CC; Gorbovskaya I; Laughlin CP; Nurmi EL; Liebermann JA; Meltzer HY; Kennedy JL; Müller DJ
    Schizophr Res; 2019 Oct; 212():204-212. PubMed ID: 31447353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
    Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
    Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.
    Sickert L; Müller DJ; Tiwari AK; Shaikh S; Zai C; De Souza R; De Luca V; Meltzer HY; Lieberman JA; Kennedy JL
    Pharmacogenomics; 2009 Jul; 10(7):1169-76. PubMed ID: 19604092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.
    Nurmi EL; Spilman SL; Whelan F; Scahill LL; Aman MG; McDougle CJ; Arnold LE; Handen B; Johnson C; Sukhodolsky DG; Posey DJ; Lecavalier L; Stigler KA; Ritz L; Tierney E; Vitiello B; McCracken JT;
    Transl Psychiatry; 2013 Jun; 3(6):e274. PubMed ID: 23799528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients.
    Kuzman MR; Medved V; Bozina N; Hotujac L; Sain I; Bilusic H
    Psychiatry Res; 2008 Sep; 160(3):308-15. PubMed ID: 18718676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain.
    Reynolds GP; Zhang Z; Zhang X
    Am J Psychiatry; 2003 Apr; 160(4):677-9. PubMed ID: 12668355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
    Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
    J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of the G-protein beta3 subunit gene (C825T) polymorphism and clinical response to olanzapine or olanzapine-related weight gain in persons with schizophrenia.
    Bishop JR; Ellingrod VL; Moline J; Miller D
    Med Sci Monit; 2006 Feb; 12(2):BR47-50. PubMed ID: 16449941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.
    Ujike H; Nomura A; Morita Y; Morio A; Okahisa Y; Kotaka T; Kodama M; Ishihara T; Kuroda S
    J Clin Psychiatry; 2008 Sep; 69(9):1416-22. PubMed ID: 19193342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Study of 60 Candidate Genes with Antipsychotic-induced Weight Gain in Schizophrenia Patients.
    Ryu S; Huh IS; Cho EY; Cho Y; Park T; Yoon SC; Joo YH; Hong KS
    Pharmacopsychiatry; 2016 Mar; 49(2):51-6. PubMed ID: 26845588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.